16-57382414-C-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_002996.6(CX3CL1):c.576C>T(p.Ser192Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00111 in 1,612,600 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0059 ( 7 hom., cov: 32)
Exomes 𝑓: 0.00061 ( 9 hom. )
Consequence
CX3CL1
NM_002996.6 synonymous
NM_002996.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.04
Genes affected
CX3CL1 (HGNC:10647): (C-X3-C motif chemokine ligand 1) This gene belongs to the CX3C subgroup of chemokines, characterized by the number of amino acids located between the conserved cysteine residues. This is the only member of the CX3C subgroup, which contains three amino acids between cysteine residues, resulting in a Cys-X-X-X-Cys configuration. The encoded protein contains an extended mucin-like stalk with a chemokine domain on top, and exists in both a membrane-anchored form where it acts as a binding molecule, or, in soluble form, as a chemotactic cytokine. The mature form of this protein can be cleaved at the cell surface, yielding different soluble forms that can interact with the G-protein coupled receptor, C-X3-C motif chemokine receptor 1 gene product. This gene plays a role in a wide range of diseases, including cancer, vasculitis, neuropathies, atherosclerosis, inflammatory diseases, and in human immunodeficiency virus infections. [provided by RefSeq, Sep 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 16-57382414-C-T is Benign according to our data. Variant chr16-57382414-C-T is described in ClinVar as [Benign]. Clinvar id is 711165.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.04 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00585 (891/152278) while in subpopulation AFR AF= 0.0202 (839/41554). AF 95% confidence interval is 0.0191. There are 7 homozygotes in gnomad4. There are 446 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 7 gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CX3CL1 | ENST00000006053.7 | c.576C>T | p.Ser192Ser | synonymous_variant | Exon 3 of 3 | 1 | NM_002996.6 | ENSP00000006053.6 | ||
CX3CL1 | ENST00000565912.1 | c.462C>T | p.Ser154Ser | synonymous_variant | Exon 2 of 2 | 1 | ENSP00000464114.1 | |||
CX3CL1 | ENST00000563383.1 | c.594C>T | p.Ser198Ser | synonymous_variant | Exon 3 of 3 | 5 | ENSP00000456830.1 | |||
CX3CL1 | ENST00000564948.1 | c.*287C>T | 3_prime_UTR_variant | Exon 2 of 2 | 3 | ENSP00000457996.1 |
Frequencies
GnomAD3 genomes AF: 0.00584 AC: 889AN: 152160Hom.: 7 Cov.: 32
GnomAD3 genomes
AF:
AC:
889
AN:
152160
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00141 AC: 351AN: 248690Hom.: 2 AF XY: 0.00106 AC XY: 143AN XY: 134892
GnomAD3 exomes
AF:
AC:
351
AN:
248690
Hom.:
AF XY:
AC XY:
143
AN XY:
134892
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000613 AC: 895AN: 1460322Hom.: 9 Cov.: 31 AF XY: 0.000527 AC XY: 383AN XY: 726532
GnomAD4 exome
AF:
AC:
895
AN:
1460322
Hom.:
Cov.:
31
AF XY:
AC XY:
383
AN XY:
726532
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00585 AC: 891AN: 152278Hom.: 7 Cov.: 32 AF XY: 0.00599 AC XY: 446AN XY: 74446
GnomAD4 genome
AF:
AC:
891
AN:
152278
Hom.:
Cov.:
32
AF XY:
AC XY:
446
AN XY:
74446
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 18, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at